Steps toward mapping the human vasculature by phage display

Nature Medicine

Volumn 8, Issue 2, 2002, Pages 121-127

  Arap, Wadih ^a   Kolonin, Mikhail G ^a   Trepel, Martin ^a   Lahdenranta, Johanna ^a   Cardó Vila, Marina ^a   Giordano, Ricardo J ^a   Mintz, Paul J ^a   Ardelt, Peter U ^a   Yao, Virginia J ^a   Vidal, Claudia I ^a   Chen, Limor ^a   Flamm, Anne ^a   Valtanen, Heli ^b   Weavind, Lisa M ^a   Hicks, Marshall E ^a   Pollock, Raphael E ^a   Botz, Gregory H ^a   Bucana, Corazon D ^a   Koivunen, Erkki ^a   Cahill, Dolores ^c   Troncoso, Patricia ^a   Baggerly, Keith A ^a   Pentz, Rebecca D ^a   Do, Kim Anh ^a   Logothetis, Christopher J ^a   Pasqualini, Renata ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE LIBRARY; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CELL SURFACE; HUMAN; IN VIVO STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

BLOOD VESSELS; HUMANS; OLIGOPEPTIDES; ORGAN SPECIFICITY; PEPTIDE LIBRARY; REPRODUCIBILITY OF RESULTS; SOFTWARE; VARIATION (GENETICS);

EID: 18244407799     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0202-121     Document Type: Article

References (35)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. In vivo phage display
4. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display
5. Organ targeting in vivo using phage display peptide libraries
6. Anti-cancer activity of targeted pro-apoptotic peptides
7. Tumor targeting with a selective gelatinase inhibitor
8. NG2 proteoglycan-binding peptides target tumor neovasculature
9. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
10. α integrins as receptors for tumor targeting by circulating ligands
11. Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
12. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors
13. Molecular adaptors for vascular-targeted adenoviral gene delivery
14. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display
15. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
16. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
17. Molecular addresses in blood vessels as targets for therapy
18. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase
19. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature
20. Genes expressed in human tumor endothelium
21. Cell surface tumor endothelial markers are conserved in mice and humans
22. Three key residues form a critical contact network in a protein folding transition state
23. RGD and other recognition sequences for integrins
24. 2 integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides
25. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
26. Bone morphogenetic protein-3 is a negative regulator of bone density
27. IL-11 activates human endothelial cells to resist immune-mediated injury
28. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma
29. Sortilin is a major protein component of Glut4-containing vesicles
30. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia
31. Thrombomodulin Ala 455Val polymorphism and risk of coronary heart disease
32. Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential
33. Therapeutic peptides revisited
34. The diagnosis of brain death
35. Implementing human research regulations